1 |
Asai T. Evaluation method for the degree of seriousness in Kawasaki disease. Acta Paediatr Jpn 1983;25:170-5
DOI
|
2 |
Leung DYM, Meissner HC, Fulton DR, Quimby F, Schlievert PM. Superantigens in Kawasaki syndrome. Clin Immunol Immunopathol 1995;77:119-26
DOI
ScienceOn
|
3 |
Bonany PJ, Bilkis MD, Gallo G, Lago N, Dennehy MV, Sosa del Valle JM, et al. Acute renal failure in typical Kawasaki disease. Pediatr Nephrol 2002;17:329-31
DOI
ScienceOn
|
4 |
Nakamura Y, Yashiro M, Uehara R, Watanabe M, Tajimi M, Oki I, et al. Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 2004;46:33-8
DOI
ScienceOn
|
5 |
Jia EZ, Yang ZJ, Zhu TB, Wang LS, Chen B, Cao KJ, et al. Serum sodium concentration is significantly associated with the angiographic characteristics of coronary atherosclerosis. Acta Pharmacol Sin 2007;28:1136-42
DOI
ScienceOn
|
6 |
De Luca L, Klein L, Udelson JE, Orlandi C, Sardella G, Fedele F, et al. Hyponatremia in patients with heart failure. Am J Cardiol 2005;96:19-23
|
7 |
Eisenhut M. Changes in renal sodium transport during a systemic inflammatory response. Pediatr Nephrol 2006;21: 1487-8
DOI
ScienceOn
|
8 |
Ohno T, Yuge T, Kariyazono H, Igarashi H, Jono K, Kinugawa N, et al. Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr 2002;161:105-11
DOI
ScienceOn
|
9 |
Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 2006;113:2606-12
DOI
ScienceOn
|
10 |
Ohta K, Seno A, Shintan N, Kato E, Yachie A, Seki H, et al. Increased levels of urinary interleukin-6 in Kawasaki disease. Eur J Pediatr 1993;152:647-9
DOI
ScienceOn
|
11 |
Dajani AS, Taubert KA, Takahashi M, Bierman FZ, Freed MD, Ferrieri P, et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994;89:916-22
PUBMED
ScienceOn
|
12 |
Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-85
PUBMED
ScienceOn
|
13 |
Han RK, Silverman ED, Newman A, McCrindle BW. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med 2000;154:694-9
PUBMED
|
14 |
Koyanagi H, Nakamura Y, Yanagawa H. Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease. Acta Paediatr 1998;87:32-6
DOI
ScienceOn
|
15 |
Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C. Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 2003; 24:145-8
DOI
ScienceOn
|
16 |
Watanabe T, Abe Y, Sato S, Uehara Y, Ikeno K, Abe T. Hyponatremia in Kawasaki disease. Pediatr Nephrol 2006; 21:778-81
DOI
ScienceOn
|
17 |
Koren G, Lavi S, Rose V, Rowe R. Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 1986; 108:388-92
DOI
|
18 |
Takahashi M. Kawasaki syndrome (mucocutaneous lymph node syndrome). In: Allen HD, Gutgesell HD, Clark EB, Driscoll DJ, editors. Moss and Adams' heart disease in infants, children, and adolescents including the fetus and young adults. 6th ed. Philadelpia : Lippinocott Williams & Wilkins Co, 2001;1216-25
|
19 |
Nakabayashi Y, Shimizu T. Hyponatremia in Kawasaki disease. Nippon Shoni Jinzobyo Gakkai Zasshi 2002;15:83-7
DOI
|
20 |
Muta H, Ishii M, Egami K, Hayasaka S, Nakamura Y, Yanagawa H, et al. Serum sodium levels in patients with Kawasaki disease. Pediatr Cardiol 2005;26:404-7
DOI
ScienceOn
|
21 |
Laxer RM, Petty RE. Hyponatremia in Kawasaki disease. Pediatrics 1982;4:655
DOI
|
22 |
Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 1998;17:1144-8
DOI
ScienceOn
|
23 |
Harada K, Yamaguchi H, Kato H. Indication for intravenous gamma globulin treatment for Kawasaki disease. In : Takahashi M, Taubert K, editors. Proceedings of the Fourth International Symposium on Kawasaki disease. American Heart Association, Dallas, 1993:459-62
|
24 |
Maeno N, Takei S, Masuda K, Akaike H, Matsuo K, Kitajima I, et al. Increased serum levels of vascular endothelial growth factor in Kawasaki disease. Pediatr Res 1998;44:596- 9
DOI
ScienceOn
|
25 |
Research Committee on Kawasaki disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo, 1984
|
26 |
Leung DYM, Chu ET, Wood N, Grady S, Meade R, Geha RS. Immno regulartory T cell abnormalities in mucocutaneous lymph node syndrome. J Immunol 1983;130:2002-4
|
27 |
Mine K, Takaya J, Hasui M, Ikemoto Y, Teraguchi M, Kobayashi Y. A case of Kawasaki disease associated with syndrome of inappropriate secretion of antidiuretic hormone. Acta Paediatr 2004;93:1547-9
DOI
ScienceOn
|
28 |
Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1776-80
PUBMED
ScienceOn
|
29 |
Suzuki H, Takeuchi T, Minami T, Shibuta S, Uemura S, Yoshikawa N. Water retention in the acute phase of Kawasaki disease: relationship between oedema and the development of coronary artery lesions. Eur J Pediatr 2003;162:856-9
DOI
ScienceOn
|
30 |
Rhodes J, King ME, Aretz HT. An 11-year-old girl with fever, hypotension and azotemia. N Engl J Med 1998;339: 1619-26
DOI
ScienceOn
|
31 |
Jibiki T, Terai M, Kohno Y. High concentrations of interleukin-8 and monocyte chemoattractant protein-1 in urine of patients with acute Kawasaki disease. Eur J Pediatr 2004; 163:749-50
DOI
ScienceOn
|
32 |
Fujiwara T, Fujiwara H, Hamashima Y. Frequency and size of coronary arterial aneurysm at necropsy in Kawasaki disease. Am J Cardiol 1987;59:808-11
DOI
ScienceOn
|
33 |
Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 1983;25:170-5
DOI
|
34 |
Beiser AS, Takahashi M, Baker AL, Sundel RP, Newburger JW. A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol 1998;81:1116-20
DOI
ScienceOn
|
35 |
Ferriero DM, Wolfsdorf JI. Hemolytic uremic syndrome associated with Kawasaki disease. Pediatrics 1981;68:405-6
PUBMED
|
36 |
Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 2006; 149:237-40
DOI
ScienceOn
|